What is the future of treating diabetes? What new solutions are available in term of therapy? How to avoid hypoglycaemia in insulin-treated patients? These

Our company operates in the very important area of healthcare, which is why we treat safety very seriously. As a result of the worrisome

In the past weeks we have all been asking ourselves whether or not we are in the risk group more vulnerable to COVID-19 and

Ongoing research is happening to understand factors that could influence the destruction of insulin producing cells in type 1 diabetes. However, for type 2

According to the latest data from IDF Diabetes Atlas, 463 million people suffer from diabetes worldwide. An estimated 232 million remain undiagnosed. The data

On 30 October 2020 the Company Supervisory Board appointed Jeremy Launders as President of Bioton S.A. Jeremy Launders is a leader with extensive experience

What impact does diabetes have on infection with COVID-19? This question was answered by Prof. Krzysztof Strojek, MD, PhD, Associate Professor in an article

In 2021 we are celebrating the 100th anniversary of the discovery of insulin. This was a real breakthrough in diabetes treatment which has saved

In January 1922, at the Toronto City Hospital, pancreas extract was used for the first time in a diabetic fourteen-year-old Leonard Thompson. Two years

“Stabilize, improve, grow” is the title of an interview with Jeremy Launders, the President of the Management Board in BIOTON S.A., for Wprost newsmagazine.